Wen Chi Chou, PhD
About Wen Chi Chou, PhD
Wen Chi Chou, PhD, is the Associate Director of Computational Biology at Bristol Myers Squibb, specializing in clinical, translational, and preclinical oncology. He has extensive experience in computational biology, genomics, and data science, with a strong background in various medical fields and a passion for translating quantitative data into biomedical decisions.
Company: Bristol Myers Squibb
Wen Chi Chou, PhD, currently serves as the Associate Director of Computational Biology (ETPS) | Clinical, Translational & Preclinical Oncology at Bristol Myers Squibb in Cambridge, Massachusetts. They have held multiple roles at the company, including Senior Principal Computational Biologist and Principal Computational Biologist within the Clinical Development Predictive Sciences (Oncology) team. These positions have allowed Dr. Chou to contribute significantly to oncology research and clinical trials.
Education and Expertise
Dr. Chou has an extensive academic background, holding a Doctor of Philosophy (Ph.D.) in Bioinformatics from The University of Georgia and a Master's Degree in Cellular and Molecular Biology from Taipei Medical University. They also earned a Bachelor's degree in Clinical Laboratory Science/Medical Technology/Technologist from Chung Shan Medical University and are pursuing an MBA at Boston College. Dr. Chou's educational journey underscores their deep expertise in computational biology, genomics, and bioinformatics.
Background in Computational Biology
Dr. Chou has a robust background in computational biology, demonstrated by their roles across various prominent institutions. Prior to their current role, they were a Computational Biologist at Takeda, held a visiting scientist position at the Broad Institute of MIT and Harvard, and served as a Team Lead in Data Science & Computational Biology at Obsidian Therapeutics. These roles involved leading computational biology projects and developing innovative data analysis methodologies.
Professional Experience
Dr. Chou has accumulated extensive professional experience across academia and industry. They've held postdoctoral research roles at Harvard Medical School and Hebrew SeniorLife, focusing on genetics epidemiology. Additionally, they have experience as a research intern at Eli Lilly and Company, and a guest lecturer at Boston University. This diverse experience has equipped Dr. Chou with a comprehensive skill set in computational, statistical analyses, and machine-learning approaches.
Achievements in Data Science and Computational Biology
Throughout their career, Dr. Chou has made significant contributions to the field of data science and computational biology. They have experience in mining OMICS data sets including transcriptomic, genomic, genetic, gut metagenomic, metabolomic, and flow cytometry data. Their work has spanned various medical fields such as oncology, gastrointestinal and liver diseases, rare diseases, vaccines, neurological disorders, bacterial infections, and osteoporosis. Their ability to translate quantitative data into actionable biomedical decisions is a hallmark of their professional achievements.